TRYCAT Pathways Link Peripheral Inflammation, Nicotine, Somatization and Depression in the Etiology and Course of Parkinson’s Disease

Publisher： Bentham Science Publishers

E-ISSN： 1996-3181|13|1|137-149

ISSN： 1871-5273

Source： CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol.13, Iss.1, 2014-02, pp. : 137-149

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Overlapping the Tryptophan Catabolite (TRYCAT) and Melatoninergic Pathways in Alzheimer's Disease

By  

Current Pharmaceutical Design, Vol. 22, Iss. 8, 2016-02 ,pp. : 1074-1085

Bentham Science Publishers

Access to resources Recommend Favorite

Entacapone in the management of Parkinson’s disease

By Waters Cheryl   Henchcliffe Claire  

Expert Opinion on Pharmacotherapy, Vol. 3, Iss. 7, 2002-07 ,pp. : 957-963

Informa Healthcare

Access to resources Recommend Favorite

Dopaminergic substitution in Parkinson’s disease

By Müller Thomas  

Expert Opinion on Pharmacotherapy, Vol. 3, Iss. 10, 2002-10 ,pp. : 1393-1403

Informa Healthcare

Access to resources Recommend Favorite

Dopamine agonists in Parkinson’s disease

By Tintner Ron   Jankovic Joseph  

Expert Opinion on Investigational Drugs, Vol. 12, Iss. 11, 2003-11 ,pp. : 1803-1820

Informa Healthcare

Access to resources Recommend Favorite

Transplantation therapy for Parkinson’s disease

By Borlongan C.V.  

Expert Opinion on Investigational Drugs, Vol. 9, Iss. 10, 2000-10 ,pp. : 2319-2330

Informa Healthcare

Access to resources Recommend Favorite